Tixel i Receives CE Certification, Expanding Access to TMA(R) Dry Eye Therapy Across EuropeAVENTURA, FL / ACCESS Newswire / September 11, 2026 / Novoxel® Ltd., developer of Tixel, today announced that Tixel i, its proprietary device for the treatment of dry eye disease, has received CE certification under EU Medical Device Regulation (MDR) certificate 725869, clearing the way for the device to be marketed and sold across the European Union.
